150 related articles for article (PubMed ID: 24969481)
1. Genetic variants of the HSD11B1 gene promoter may be protective against polycystic ovary syndrome.
Grolmusz VK; Acs OD; Feldman-Kovács K; Szappanos Á; Stenczer B; Fekete T; Szendei G; Reismann P; Rácz K; Patócs A
Mol Biol Rep; 2014 Sep; 41(9):5961-9. PubMed ID: 24969481
[TBL] [Abstract][Full Text] [Related]
2. The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women.
Feldman K; Szappanos A; Butz H; Grolmusz V; Majnik J; Likó I; Kriszt B; Lakatos P; Tóth M; Rácz K; Patócs A
Steroids; 2012 Nov; 77(13):1345-51. PubMed ID: 22986073
[TBL] [Abstract][Full Text] [Related]
3. Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage.
Chua AK; Azziz R; Goodarzi MO
Mol Hum Reprod; 2012 Jun; 18(6):320-4. PubMed ID: 22238371
[TBL] [Abstract][Full Text] [Related]
4. Association Analysis between the Polymorphisms of HSD11B1 and H6PD and Risk of Polycystic Ovary Syndrome in Chinese Population.
Ju R; Wu W; Tang Q; Wu D; Xia Y; Wu J; Wang X
PLoS One; 2015; 10(10):e0140326. PubMed ID: 26452272
[TBL] [Abstract][Full Text] [Related]
5. A combination of polymorphisms in HSD11B1 associates with in vivo 11{beta}-HSD1 activity and metabolic syndrome in women with and without polycystic ovary syndrome.
Gambineri A; Tomassoni F; Munarini A; Stimson RH; Mioni R; Pagotto U; Chapman KE; Andrew R; Mantovani V; Pasquali R; Walker BR
Eur J Endocrinol; 2011 Aug; 165(2):283-92. PubMed ID: 21622477
[TBL] [Abstract][Full Text] [Related]
6. A study of the hexose-6-phosphate dehydrogenase gene R453Q and 11beta-hydroxysteroid dehydrogenase type 1 gene 83557insA polymorphisms in the polycystic ovary syndrome.
San Millán JL; Botella-Carretero JI; Alvarez-Blasco F; Luque-Ramírez M; Sancho J; Moghetti P; Escobar-Morreale HF
J Clin Endocrinol Metab; 2005 Jul; 90(7):4157-62. PubMed ID: 15827106
[TBL] [Abstract][Full Text] [Related]
7. Association between Selected Polymorphisms rs12086634, rs846910, rs4844880, rs3753519 of 11β-Hydroxysteroid Dehydrogenase Type 1 (
Szweda-Gandor N; Śnit M; Grzeszczak W
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639470
[TBL] [Abstract][Full Text] [Related]
8. A functional GNAQ promoter haplotype is associated with altered Gq expression and with insulin resistance and obesity in women with polycystic ovary syndrome.
Klenke S; Tan S; Hahn S; Mann K; Hauner H; Manthey I; Peters J; Siffert W; Frey UH
Pharmacogenet Genomics; 2010 Aug; 20(8):476-84. PubMed ID: 20562673
[TBL] [Abstract][Full Text] [Related]
9. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population.
Ben Salem A; Megdich F; Kacem O; Souayeh M; Hachani Ben Ali F; Hizem S; Janhai F; Ajina M; Abu-Elmagd M; Assidi M; Al Qahtani MH; Mahjoub T
BMC Genomics; 2016 Oct; 17(Suppl 9):748. PubMed ID: 27766947
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
Gambineri A; Vicennati V; Genghini S; Tomassoni F; Pagotto U; Pasquali R; Walker BR
J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific dysregulation of 11β-hydroxysteroid dehydrogenase type 1 in overweight/obese women with polycystic ovary syndrome compared with weight-matched controls.
Gambineri A; Fanelli F; Tomassoni F; Munarini A; Pagotto U; Andrew R; Walker BR; Pasquali R
Eur J Endocrinol; 2014 Jul; 171(1):47-57. PubMed ID: 24743397
[TBL] [Abstract][Full Text] [Related]
13. Variants implicated in cortisone reductase deficiency do not contribute to susceptibility to common forms of polycystic ovary syndrome.
Draper N; Powell BL; Franks S; Conway GS; Stewart PM; McCarthy MI
Clin Endocrinol (Oxf); 2006 Jul; 65(1):64-70. PubMed ID: 16817821
[TBL] [Abstract][Full Text] [Related]
14. Association analysis between the tag single nucleotide polymorphisms of DENND1A and the risk of polycystic ovary syndrome in Chinese Han women.
Zhu YN; Zhang YT; Liu Q; Shen SM; Zou X; Cao YX; Wang WJ; Yi L; Gao Q; Yang WD; Wang Y
BMC Med Genet; 2020 Jan; 21(1):14. PubMed ID: 31941453
[TBL] [Abstract][Full Text] [Related]
15. Regulatory effect of common promoter polymorphisms on the expression of the 11beta-hydroxysteroid dehydrogenase type 1 gene.
Ku YH; Koo BK; Kwak SH; Cho YM; Shin HD; Lee HK; Kim Y; Choi JW; Oh B; Park KS
Horm Res; 2009; 72(1):25-32. PubMed ID: 19571556
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome.
Valkenburg O; Uitterlinden AG; Themmen AP; de Jong FH; Hofman A; Fauser BC; Laven JS
Hum Reprod; 2011 Oct; 26(10):2902-11. PubMed ID: 21803757
[TBL] [Abstract][Full Text] [Related]
17. FTO gene variants are not associated with polycystic ovary syndrome in women from Southern Brazil.
Ramos RB; Spritzer PM
Gene; 2015 Apr; 560(1):25-9. PubMed ID: 25592819
[TBL] [Abstract][Full Text] [Related]
18. Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.
Santos BR; Lecke SB; Spritzer PM
PLoS One; 2017; 12(3):e0173695. PubMed ID: 28278285
[TBL] [Abstract][Full Text] [Related]
19. DENND1A gene variants in Bahraini Arab women with polycystic ovary syndrome.
Gammoh E; Arekat MR; Saldhana FL; Madan S; Ebrahim BH; Almawi WY
Gene; 2015 Apr; 560(1):30-3. PubMed ID: 25626177
[TBL] [Abstract][Full Text] [Related]
20. Nonreplication of the type 5 17beta-hydroxysteroid dehydrogenase gene association with polycystic ovary syndrome.
Goodarzi MO; Jones MR; Antoine HJ; Pall M; Chen YD; Azziz R
J Clin Endocrinol Metab; 2008 Jan; 93(1):300-3. PubMed ID: 17940109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
